Oric Pharmaceuticals Inc (ORIC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $814.71M
Last updated: Nov 17, 2026 at 11:06 AM ET
Oric Pharmaceuticals Inc (ORIC) Earnings: Report Dates and Results
Oric Pharmaceuticals (ORIC) is expected to report earnings on Feb 22, 2027. In the quarter ended Jun 30, 2026, Oric Pharmaceuticals reported EPS of -$0.38, below the -$0.36 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ORIC has an expected report date of Feb 22, 2027.
Earnings History
Of the 26 quarters below that had an estimate, ORIC beat 12, missed 13 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2020, when EPS landed 115.38% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.38 | -$0.36 | -$0.40 - -$0.30 | -5.56% | Miss | N/A | 13 | 2 up, 7 down | Aug 3, 2026 |
| Mar 31, 2026 | -$0.34 | -$0.32 | -$0.37 - -$0.26 | -6.25% | Miss | N/A | 15 | 1 up, 1 down | May 4, 2026 |
| Dec 31, 2025 | -$0.30 | -$0.37 | -$0.51 - -$0.30 | +18.23% | Beat | N/A | 14 | N/A | Feb 23, 2026 |
| Sep 30, 2025 | -$0.33 | -$0.40 | -$0.47 - -$0.31 | +17.50% | Beat | N/A | 11 | 5 up, 3 down | Nov 13, 2025 |
| Jun 30, 2025 | -$0.47 | -$0.44 | -$0.53 - -$0.36 | -6.82% | Miss | N/A | 9 | 6 up, 1 down | Aug 12, 2025 |
| Mar 31, 2025 | -$0.42 | -$0.50 | -$0.54 - -$0.43 | +16.00% | Beat | N/A | 8 | 1 up, 1 down | May 5, 2025 |
| Dec 31, 2024 | -$0.51 | -$0.51 | -$0.55 - -$0.39 | -0.31% | Miss | N/A | 10 | N/A | Feb 18, 2025 |
| Sep 30, 2024 | -$0.49 | -$0.47 | -$0.52 - -$0.38 | -4.26% | Miss | N/A | 12 | 0 up, 0 down | Nov 12, 2024 |
| Jun 30, 2024 | -$0.45 | -$0.41 | -$0.44 - -$0.38 | -9.76% | Miss | N/A | 9 | 0 up, 0 down | Aug 12, 2024 |
| Mar 31, 2024 | -$0.37 | -$0.43 | -$0.52 - -$0.39 | +13.95% | Beat | N/A | 9 | 1 up, 0 down | May 6, 2024 |
| Dec 31, 2023 | -$0.49 | -$0.49 | -$0.55 - -$0.44 | 0.00% | In line | N/A | 9 | 0 up, 0 down | Mar 11, 2024 |
| Sep 30, 2023 | -$0.44 | -$0.46 | -$0.51 - -$0.42 | +4.35% | Beat | N/A | 8 | 0 up, 0 down | Nov 6, 2023 |
| Jun 30, 2023 | -$0.50 | -$0.57 | -$0.60 - -$0.51 | +12.28% | Beat | N/A | 7 | 0 up, 0 down | Aug 10, 2023 |
| Mar 31, 2023 | -$0.53 | -$0.54 | -$0.60 - -$0.49 | +1.85% | Beat | N/A | 6 | 0 up, 0 down | May 8, 2023 |
| Dec 31, 2022 | -$0.52 | -$0.54 | -$0.58 - -$0.53 | +3.70% | Beat | N/A | 6 | 0 up, 0 down | Mar 16, 2023 |
| Sep 30, 2022 | -$0.63 | -$0.55 | -$0.58 - -$0.53 | -14.55% | Miss | N/A | 7 | 0 up, 0 down | Nov 7, 2022 |
| Jun 30, 2022 | -$0.51 | -$0.60 | N/A | +15.00% | Beat | N/A | N/A | 0 up, 0 down | Aug 11, 2022 |
| Mar 31, 2022 | -$0.59 | -$0.57 | -$0.61 - -$0.51 | -3.51% | Miss | N/A | 7 | 1 up, 0 down | May 9, 2022 |
| Dec 31, 2021 | -$0.58 | -$0.57 | -$0.71 - -$0.49 | -1.75% | Miss | N/A | 7 | 0 up, 0 down | Mar 21, 2022 |
| Sep 30, 2021 | -$0.47 | -$0.58 | -$0.64 - -$0.53 | +18.97% | Beat | N/A | 7 | N/A | Nov 8, 2021 |
| Jun 30, 2021 | -$0.57 | -$0.49 | -$0.53 - -$0.47 | -16.33% | Miss | N/A | 7 | N/A | Aug 10, 2021 |
| Mar 31, 2021 | -$0.45 | -$0.48 | -$0.51 - -$0.45 | +6.25% | Beat | N/A | 7 | N/A | May 6, 2021 |
| Dec 31, 2020 | -$0.84 | -$0.46 | -$0.69 - -$0.36 | -82.61% | Miss | N/A | 6 | N/A | Mar 23, 2021 |
| Sep 30, 2020 | -$0.84 | -$0.39 | -$0.43 - -$0.33 | -115.38% | Miss | N/A | 7 | N/A | Nov 5, 2020 |
| Jun 30, 2020 | -$0.51 | -$0.40 | -$0.67 - -$0.21 | -27.50% | Miss | N/A | 6 | N/A | Aug 5, 2020 |
| Mar 31, 2020 | -$0.42 | -$0.46 | N/A | +8.70% | Beat | N/A | N/A | N/A | Apr 23, 2020 |
| Dec 31, 2019 | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 28, 2020 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.52, after -$1.82 the year before. It was -$0.08 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.52 | N/A |
| Dec 31, 2024 | -$1.82 | N/A |
| Dec 31, 2023 | -$1.96 | N/A |
| Dec 31, 2022 | -$2.25 | N/A |
| Dec 31, 2021 | -$2.07 | N/A |
| Dec 31, 2020 | -$2.61 | N/A |
| Dec 31, 2019 | -$0.08 | N/A |
Frequently Asked Questions About ORIC
When is Oric Pharmaceuticals's next earnings date?
Oric Pharmaceuticals's next earnings report is expected for Feb 22, 2027.
Did ORIC beat earnings estimates last quarter?
No. Oric Pharmaceuticals reported EPS of -$0.38 for the quarter ended Jun 30, 2026, below the -$0.36 estimate by 5.56%.
What EPS do analysts expect from ORIC next quarter?
The consensus EPS estimate for Oric Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.41 from 16 analysts, with estimates from -$0.46 to -$0.35.
How often does ORIC beat earnings estimates?
Oric Pharmaceuticals beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of +3.57%.
ORIC pages: Overview, Earnings, Forecast, Financials, Competitors